Table 1 Patients’ characteristics and procedures. Data are presented for the entire cohort and according to nodal status. Continuous variables are presented as mean ± SD
From: Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement
Variable | N0 (89) | N1 (214) | Total (303) | p |
|---|---|---|---|---|
Age | 65.7 ± 10.7 | 67.4 ± 10.5 | 66.9 ± 10.6 | 0.223 |
Sex, Females | 40.7% | 47.5% | 45.5% | 0.348 |
ASA score | 2.3 ± 0.7 | 2.5 ± 0.7 | 2.4 ± 0.7 | 0.379 |
BMI | 23.8 ± 2.9 | 24.1 ± 3.2 | 24.0 ± 3.1 | 0.651 |
Comorbidities | 57.0% | 63.5% | 61.7% | 0.381 |
CEA (UI/ml) | 15.7 ± 33.7 | 10.7 ± 19.1 | 12.0 ± 23.6 | 0.452 |
CA 19.9 (UI/ml) | 592 ± 1276 | 644 ± 1375 | 637.0 ± 1345 | 0.831 |
Albumin (g/dl) | 3.8 ± 0.6 | 3.7 ± 0.6 | 3.7 ± 0.6 | 0.258 |
Bilirubin (mg/dl) | 6.7 ± 15.7 | 6.2 ± 6.3 | 6.3 ± 9.7 | 0.745 |
Tumor diameter at CT, mm | 36.3 ± 22.6 | 31.6 ± 11.7 | 32.9 ± 15.4 | 0.103 |
Surgery | 0.747 | |||
PD, number | 68 | 165 | 233 | |
LP, number | 18 | 42 | 60 | |
TP, number | 3 | 7 | 10 |